Delivery Order SPE2DB22D3501-SPE2DB24FUL77
Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $7.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,072.44, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of INFUVITE PEDIATRIC VIAL 5ML. The award, valued at $4,647.78, is a Firm Fixed Price Delivery Order with a completion date of September 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying this specialized...
- This is a federal contract award made by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product. The contract has a ceiling value of $11,605.35 and is a firm fixed price delivery order. It is not designated as a set-aside contract. The contract has an ultimate completion date of July 14,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,870.36, is for the delivery of Infuvite Pediatric Vial 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order type, with a completion date of January 22, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $25.8K delivery order to AmerisourceBergen Drug Corp for INFUVITE PEDIATRIC VIAL 5ML, a pediatric intravenous nutritional product. Issued on June 11, 2025, with an ultimate completion date of June 12, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $33,220.58 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order is non-competitive and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and medical supply provider to federal healthcare systems, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,499.55 and a performance period ending on June 12, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety thousand ninety-one dollars to Amerisourcebergen Drug Corporation for 4561821710 INFUVITE PEDIATRIC VIAL 5ML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the requested pediatric infusion vials to the agency from its place of performance in Conshohocken, Pennsylvania under a one day period of performance between August 15-16, 2023. As a major distributor of pharmaceuticals...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUL77Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563574179 INFUVITE PEDIATRIC VIAL 5ML. The contract has a potential value of $7,746.30 and a completion date of February 7, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 5/7/24, 11:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 2/6/24 |